Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;14:461-468

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imanishi, M.
Right arrow Articles by Omae, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imanishi, M.
Right arrow Articles by Omae, T.

Hypertension, Vol 14, 461-468, Copyright © 1989 by American Heart Association


ARTICLES

Aspirin lowers blood pressure in patients with renovascular hypertension

M Imanishi, M Kawamura, S Akabane, Y Matsushima, M Kuramochi, K Ito, M Ohta, K Kimura, M Takamiya and T Omae
Division of Hypertension and Nephrology, National Cardiovascular Center, Osaka, Japan.

To clarify the role of renal prostanoid in hyperreninemia and high blood pressure in human renovascular hypertension, we measured prostaglandin E2 and renin activity in renal venous and abdominal aortic plasma before and after the intravenous administration of the cyclooxygenase inhibitor, aspirin DL-lysine. Subjects were six patients with unilateral renovascular hypertension and six with essential hypertension. In patients with renovascular hypertension, prostaglandin E2 concentration in renal venous plasma from the stenotic kidney was 9.25 +/- 1.48 pg/ml, which was significantly higher (p less than 0.01) than the concentration in the renal venous plasma from the normal kidney (4.97 +/- 1.02 pg/ml) or in the aortic plasma (2.59 +/- 0.15 pg/ml). Plasma renin activity was also higher in the renal vein of the stenotic kidney than in the other two sites. The stenotic side/normal side ratio of the renal venous prostaglandin E2 correlated significantly with a renin ratio greater than 1.5 (r = 0.8211, p less than 0.05). Intravenous injection of aspirin DL-lysine (18 mg/kg) 30 minutes later markedly suppressed prostaglandin E2 and renin levels at all sites and clearly lowered arterial blood pressure (mean: from 120 +/- 6 to 110 +/- 5 mm Hg, p less than 0.01). The reduction in blood pressure correlated significantly with the suppression of plasma renin activity in the aorta (p less than 0.05) and in the renal vein of the stenotic kidney (p less than 0.01). Conversely, in patients with essential hypertension, aspirin had little effect on renin levels and increased mean blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
D. G. Hackam, J. D. Spence, A. X. Garg, and S. C. Textor
Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
Hypertension, December 1, 2007; 50(6): 998 - 1003.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. J. Welch, K. Patel, P. Modlinger, M. Mendonca, N. Kawada, K. Dennehy, S. Aslam, and C. S. Wilcox
Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2644 - H2649.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
F. Saremi, H. Jadvar, and M. E. Siegel
Pharmacologic Interventions in Nuclear Radiology: Indications, Imaging Protocols, and Clinical Results
RadioGraphics, May 1, 2002; 22(3): 477 - 490.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Imanishi, T. Tsuji, S. Nakamura, and M. Takamiya
Prostaglandin I2/E2 Ratios in Unilateral Renovascular Hypertension of Different Severities
Hypertension, July 1, 2001; 38(1): 23 - 29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. D. Breyer and R. M. Breyer
Prostaglandin E receptors and the kidney
Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-L. Wang, H.-F. Cheng, and R. C. Harris
Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension
Hypertension, July 1, 1999; 34(1): 96 - 101.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Imanishi, S. Akabane, M. Takamiya, M. Kawamura, Y. Matsushima, M. Kuramochi, and T. Omae
Critical Degree of Renal Arterial Stenosis That Causes Hypertension in Dogs
Angiology, October 1, 1992; 43(10): 833 - 842.
[Abstract] [PDF]